In Reply: The benefits and harms of breast cancer screening

The Lancet

Volumn 381, Issue 9869, 2013, Pages 802-

  Duffy, Stephen W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER SCREENING; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LETTER; PRIORITY JOURNAL; BREAST TUMOR; FEMALE; MASS SCREENING; METHODOLOGY; NOTE;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING;

EID: 85046983918     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60624-8     Document Type: Letter

References (4)

1. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86.
2. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study 2: 13-year results of a randomised trial in women aged 50-59 years. J Natl Cancer Inst 2000;92: 1490-99.
3. Shapiro S. Periodic screening for breast cancer: the Health Insurance Plan project and its sequelae, 1963-1986. Baltimore: Johns Hopkins University Press, 1988.
4. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39: 2772-82.